1. A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract. (31st December 2020) Authors: Sarfaty, Michal; Whiting, Karissa; Teo, Min Yuen; Lee, Chung‐Han; Peters, Vanessa; Durocher, Jennifer; Regazzi, Ashley M.; McCoy, Asia S.; Hettich, Grace; Jungbluth, Achim A.; Al‐Ahmadie, Hikmat; Ostrovnaya, Irina; Chaim, Joshua; Bajorin, Dean F.; Rosenberg, Jonathan E.; Iyer, Gopa; Funt, Samuel A. Journal: Cancer medicine Issue: Volume 10:Number 3(2021) Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial. Issue 12 (20th April 2022) Authors: Funt, Samuel A.; Lattanzi, Michael; Whiting, Karissa; Al-Ahmadie, Hikmat; Quinlan, Colleen; Teo, Min Yuen; Lee, Chung-Han; Aggen, David; Zimmerman, Danielle; McHugh, Deaglan; Apollo, Arlyn; Durdin, Trey D.; Truong, Hong; Kamradt, Jeffrey; Khalil, Maged; Lash, Bradley; Ostrovnaya, Irina; McCoy, As... Journal: Journal of clinical oncology Issue: Volume 40:Issue 12(2022) Page Start: 1312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗